MADELINE BETZ: Open Payments
NPI 1144079955 · APO, AE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 13 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $21 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| PFIZER INC. | 2 | $42 |
| Novo Nordisk Inc | 2 | $37 |
| Lilly USA, LLC | 1 | $26 |
| Medtronic, Inc. | 1 | $18 |
| ACADIA Pharmaceuticals Inc | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| SANOFI-AVENTIS U.S. LLC | 1 | $14 |
Products named: PREVNAR 20, MOUNJARO, GVOKE HYPOPEN, Wegovy, RECORLEV, INCEPTIV, DAYBUE, ELIQUIS.
Industry payments across AE — which companies pay providers there.
